Header Logo

Connection

Mona Mojtahedzadeh to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Mona Mojtahedzadeh has written about Antibodies, Bispecific.
Mona Mojtahedzadeh
Connection Strength
0.188
Antibodies, Bispecific
  1. Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia. Cancer. 2022 Feb 01; 128(3):529-535.
    View in: PubMed
    Score: 0.188
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.